Abstract510.1182/blood-2019-122923Results from an Expanded Access Program of Anti-CD3/CD7 Immunotoxin Combination (T-Guard®) for the Treatment of Steroid-Refractory Acute GvhdNov 13, 2019BloodLenneke F J Groningen + 7 more +7RelevantCiteListenSave